Noriyo Nagata

InstitutionNational Institute of Infectious Diseases
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in March 2020 and Spetember 2020 and July 2021
    All Publications
    Bar chart showing 97 publications over 24 distinct years, with a maximum of 9 publications in 2006
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nomura T, Yamamoto H, Nishizawa M, Hau TTT, Harada S, Ishii H, Seki S, Nakamura-Hoshi M, Okazaki M, Daigen S, Kawana-Tachikawa A, Nagata N, Iwata-Yoshikawa N, Shiwa N, Iida S, Katano H, Suzuki T, Park ES, Maeda K, Suzaki Y, Ami Y, Matano T. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques. PLoS Pathog. 2021 07; 17(7):e1009668. PMID: 34280241.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122. PMID: 32988731.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    3. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020 03 31; 117(13):7001-7003. PMID: 32165541.
      Citations: 393     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    4. Sekimukai H, Iwata-Yoshikawa N, Fukushi S, Tani H, Kataoka M, Suzuki T, Hasegawa H, Niikura K, Arai K, Nagata N. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiol Immunol. 2020 Jan; 64(1):33-51. PMID: 31692019.
      Citations: 42     Fields:    Translation:AnimalsCellsPHPublic Health
    5. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Kotani O, Sato H, Sekimukai H, Fukushi S, Suzuki T, Sato Y, Takeda M, Tashiro M, Hasegawa H, Nagata N. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus. J Virol. 2019 03 15; 93(6). PMID: 30626685.
      Citations: 22     Fields:    Translation:AnimalsCells
    6. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. J Virol. 2019 03 15; 93(6). PMID: 30626688.
      Citations: 248     Fields:    Translation:HumansAnimalsCells
    7. Fukushi S, Fukuma A, Kurosu T, Watanabe S, Shimojima M, Shirato K, Iwata-Yoshikawa N, Nagata N, Ohnishi K, Ato M, Melaku SK, Sentsui H, Saijo M. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA. J Virol Methods. 2018 01; 251:22-29. PMID: 28993122.
      Citations: 16     Fields:    Translation:AnimalsCells
    8. Iwata-Yoshikawa N, Fukushi S, Fukuma A, Suzuki T, Takeda M, Tashiro M, Hasegawa H, Nagata N. Non Susceptibility of Neonatal and Adult Rats against the Middle East Respiratory Syndrome Coronavirus. Jpn J Infect Dis. 2016 Nov 22; 69(6):510-516. PMID: 27000459.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    9. Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, Tashiro M, Sata T, Hasegawa H, Nagata N. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014 Aug; 88(15):8597-614. PMID: 24850731.
      Citations: 54     Fields:    Translation:AnimalsCells
    10. Kotani O, Shirato K, Nagata N, Ikeda H, Takahashi K, Taguchi F. Neuropathogenesis of a mouse-adapted porcine epidemic diarrhea virus infection in suckling mice. J Gen Virol. 2013 Apr; 94(Pt 4):831-836. PMID: 23239569.
      Citations:    Fields:    Translation:AnimalsCells
    11. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010 Dec; 84(24):12658-64. PMID: 20926566.
      Citations: 329     Fields:    Translation:HumansAnimalsCells
    12. Watanabe S, Masangkay JS, Nagata N, Morikawa S, Mizutani T, Fukushi S, Alviola P, Omatsu T, Ueda N, Iha K, Taniguchi S, Fujii H, Tsuda S, Endoh M, Kato K, Tohya Y, Kyuwa S, Yoshikawa Y, Akashi H. Bat coronaviruses and experimental infection of bats, the Philippines. Emerg Infect Dis. 2010 Aug; 16(8):1217-23. PMID: 20678314.
      Citations: 74     Fields:    Translation:AnimalsCells
    13. Nagata N, Iwata-Yoshikawa N, Taguchi F. Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models. Vet Pathol. 2010 Sep; 47(5):881-92. PMID: 20664013.
      Citations: 16     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. Haga S, Nagata N, Okamura T, Yamamoto N, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antiviral Res. 2010 Mar; 85(3):551-5. PMID: 19995578.
      Citations: 62     Fields:    Translation:HumansAnimalsCells
    15. Ishii K, Hasegawa H, Nagata N, Ami Y, Fukushi S, Taguchi F, Tsunetsugu-Yokota Y. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol Immunol. 2009 Feb; 53(2):75-82. PMID: 19291090.
      Citations: 11     Fields:    Translation:AnimalsCells
    16. Nagata N, Iwata N, Hasegawa H, Fukushi S, Harashima A, Sato Y, Saijo M, Taguchi F, Morikawa S, Sata T. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol. 2008 Jun; 172(6):1625-37. PMID: 18467696.
      Citations: 52     Fields:    Translation:HumansAnimalsCells
    17. Ami Y, Nagata N, Shirato K, Watanabe R, Iwata N, Nakagaki K, Fukushi S, Saijo M, Morikawa S, Taguchi F. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol Immunol. 2008 Feb; 52(2):118-27. PMID: 18380809.
      Citations: 10     Fields:    Translation:AnimalsCells
    18. Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int J Exp Pathol. 2007 Dec; 88(6):403-14. PMID: 18039277.
      Citations: 6     Fields:    Translation:AnimalsCells
    19. Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol. 2007 Feb; 81(4):1848-57. PMID: 17151094.
      Citations: 30     Fields:    Translation:AnimalsCells
    20. Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology. 2006 Aug 01; 351(2):368-80. PMID: 16678878.
      Citations: 10     Fields:    Translation:AnimalsCells
    21. Nagata N, Iwata N, Hasegawa H, Asahi-Ozaki Y, Sato Y, Harashima A, Morikawa S, Saijo M, Itamura S, Saito T, Odagiri T, Tashiro M, Ami Y, Sata T. Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals. Adv Exp Med Biol. 2006; 581:515-8. PMID: 17037588.
      Citations:    Fields:    Translation:AnimalsCells
    22. Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Tashiro M, Suzuki T, Taguchi F, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Highly attenuated vaccinia virus DIs as a potential SARS vaccine. Adv Exp Med Biol. 2006; 581:593-6. PMID: 17037603.
      Citations:    Fields:    Translation:HumansAnimalsCells
    23. Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Antiviral Res. 2005 Jun; 66(2-3):159-63. PMID: 15911031.
      Citations: 34     Fields:    Translation:AnimalsCells
    24. Nakajima N, Asahi-Ozaki Y, Nagata N, Sato Y, Dizon F, Paladin FJ, Olveda RM, Odagiri T, Tashio M, Sata T. SARS coronavirus-infected cells in lung detected by new in situ hybridization technique. Jpn J Infect Dis. 2003 Jun; 56(3):139-41. PMID: 12944688.
      Citations: 8     Fields:    Translation:HumansCells